Medicines and Medical Devices bill – a new model for UK life sciences?

Richard Coxon, director, life sciences, Dassault Systèmes, examines the potential ramifications of the UK’s Medicines and Medical Devices bill.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: